Tempus AI launched its HRD-RNA algorithm, an AI-driven model for identifying Homologous Recombination Deficiency in cancer patients. The company also partnered with Median Technologies to integrate ...
Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...
India Today on MSN
Goa's AI X-ray breakthrough is catching lung cancer before it kills
A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...
Dr. Douglas Wood, Henry N. Harkins Endowed Professor, chair of the UW Medicine department of surgery, and recipient of the UW ...
Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.
Sora Ely, MD, emphasized that national lung cancer screening rates remain below 10%, underscoring the urgent need for greater awareness and uptake.
Lung cancer in never smokers is rising, with distinct risks and biology, highlighting the need for tailored screening, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results